Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
As of close of business last night, Elanco Animal Health Inc’s stock clocked out at $18.78, up 2.45% from its previous closing price of $18.33. In other words, the price has increased by $2.45 from its previous closing price. On the day, 3.6 million shares were traded. ELAN stock price reached its highest trading level at $18.9 during the session, while it also had its lowest trading level at $18.35.
Ratios:
To gain a deeper understanding of ELAN’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 17.31 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 25.85. For the most recent quarter (mrq), Quick Ratio is recorded 1.40 and its Current Ratio is at 2.60. In the meantime, Its Debt-to-Equity ratio is 0.62 whereas as Long-Term Debt/Eq ratio is at 0.61.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 11 ’25 when Todd S and Jennifer G Young Li bought 49,333 shares for $16.82 per share.
Kurzius Lawrence Erik bought 10,000 shares of ELAN for $109,000 on Mar 07 ’25. The Director now owns 101,459 shares after completing the transaction at $10.90 per share. On Mar 11 ’25, another insider, Kurzius Lawrence Erik, who serves as the Director of the company, bought 10,000 shares for $10.20 each. As a result, the insider paid 102,000 and bolstered with 111,459 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELAN now has a Market Capitalization of 9330167808 and an Enterprise Value of 13000161280. As of this moment, Elanco’s Price-to-Earnings (P/E) ratio for their current fiscal year is 21.52, and their Forward P/E ratio for the next fiscal year is 19.03. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.91. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.08 while its Price-to-Book (P/B) ratio in mrq is 1.38. Its current Enterprise Value per Revenue stands at 2.899 whereas that against EBITDA is 15.44.
Stock Price History:
The Beta on a monthly basis for ELAN is 1.64, which has changed by 0.29785764 over the last 52 weeks, in comparison to a change of 0.17089343 over the same period for the S&P500. Over the past 52 weeks, ELAN has reached a high of $19.08, while it has fallen to a 52-week low of $8.02. The 50-Day Moving Average of the stock is 15.84%, while the 200-Day Moving Average is calculated to be 46.44%.
Shares Statistics:
It appears that ELAN traded 6.96M shares on average per day over the past three months and 13510990 shares per day over the past ten days. A total of 496.65M shares are outstanding, with a floating share count of 492.11M. Insiders hold about 0.95% of the company’s shares, while institutions hold 108.97% stake in the company. Shares short for ELAN as of 1756425600 were 25817794 with a Short Ratio of 3.71, compared to 1753920000 on 23961864. Therefore, it implies a Short% of Shares Outstanding of 25817794 and a Short% of Float of 7.180000000000001.
